CANSLIM - COAST TO COAST Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : CANSLIM - COAST TO COAST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: froche who wrote (4341)	2/18/1999 5:03:00 PM
From: kendall harmon	of 6445

Firm: Hambrecht & Quist Date: 2/18/99 Total Renal Care Holdings, Inc. (TRL) BUY $9.00 FY98 A: 1.22 FY99 E: - Rob Lunbeck rlunbeck@hamquist.com TRC: Stock Crushed on Disappointing Report; Cut Rating and Estimates Total Renal Care (TRC) reported 4Q98 revenue and recurring EPS of $339.2 mil. and $0.30, below our estimates of $345.6 mil. and $0.37, respectively. Excluding certain unusual expenses in the quarter, it appears TRC would have reported EPS of $0.35. TRC also reported a $12.3 mil. charge primarily related to acquired A/R. We have lowered our rating to BUY and expect to cut our 1999 EPS estimate to the $1.55 range. At $9 the stock appears very cheap.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next